EAGLE PHARMACEUTICALS, INC.【EGRX】Balance sheet

Market cap

$14.29K

P/E ratio

	2014/09	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12
Cash and cash equivalents	23	79	53	115	79	110	103	98	55
Marketable securities, current	20	-	-	-	-	-	-	-	-
Total cash & short-term investments	43	79	53	115	79	110	103	98	55
Accounts receivable, net	7	26	42	54	66	48	51	41	72
Inventories	1	15	3	5	8	7	8	22	48
Total current assets	53	122	109	189	164	179	166	173	189
Property, plant and equipment, net	0	2	3	7	2	2	2	2	1
Total non-current assets	0	2	105	81	75	75	87	81	217
Total assets	53	125	214	270	239	255	253	254	406
Accounts payable	4	4	15	12	10	5	6	16	19
Long-term debt, current	-	-	-	5	6	5	8	26	6
Total current liabilities	20	34	41	47	40	39	38	74	111
Long-term debt, non-current	-	-	-	43	38	34	25	-	56
Total non-current liabilities	-	-	-	-	-	37	29	3	62
Total liabilities	-	-	-	-	-	75	67	77	173
Common stock and paid-in capital	137	197	214	234	256	279	305	326	366
Retained earnings	-104	-107	-26	26	58	73	84	76	112
Stockholders' equity	33	90	151	179	161	179	186	176	234
Total debt	-	-	-	48	44	39	33	26	62
Net debt	-	-	-	-67	-34	-71	-70	-72	7
D/E ratio (%)	-	-	-	26.7	27.6	21.5	17.8	14.5	26.7
Working capital